title: Safety of ciprofloxacin based on phase IV studies ("Anwendungsbeobachtung") in the Federal Republic of Germany.
authors.affiliation: Institute of Drug Safety, Bayer AG, Wuppertal, Federal Republic of Germany.
authors.forename: C
authors.initials: C
authors.lastname: Reiter
authors.forename: M
authors.initials: M
authors.lastname: Pfeiffer
authors.forename: R N
authors.initials: RN
authors.lastname: Hullman
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000188:drug therapy; D002648:Child; D002939:Ciprofloxacin / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012449:Safety; D011795:Surveys and Questionnaires
chemical_list: D002939:Ciprofloxacin